BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20571502)

  • 1. Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation.
    Low D; Chen KS
    Eur J Hum Genet; 2010 Nov; 18(11):1228-35. PubMed ID: 20571502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE3A regulates MC1R expression: a link to hypopigmentation in Angelman syndrome.
    Low D; Chen KS
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):944-52. PubMed ID: 21733131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imprinting effects of UBE3A loss on synaptic gene networks and Wnt signaling pathways.
    Lopez SJ; Laufer BI; Beitnere U; Berg EL; Silverman JL; O'Geen H; Segal DJ; LaSalle JM
    Hum Mol Genet; 2019 Nov; 28(22):3842-3852. PubMed ID: 31625566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.
    Gustin RM; Bichell TJ; Bubser M; Daily J; Filonova I; Mrelashvili D; Deutch AY; Colbran RJ; Weeber EJ; Haas KF
    Neurobiol Dis; 2010 Sep; 39(3):283-91. PubMed ID: 20423730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Nociception in Angelman Syndrome Model Mice.
    McCoy ES; Taylor-Blake B; Aita M; Simon JM; Philpot BD; Zylka MJ
    J Neurosci; 2017 Oct; 37(42):10230-10239. PubMed ID: 28931574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
    Samaco RC; Hogart A; LaSalle JM
    Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase.
    Reiter LT; Seagroves TN; Bowers M; Bier E
    Hum Mol Genet; 2006 Sep; 15(18):2825-35. PubMed ID: 16905559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome.
    Wang T; Wang J; Wang J; Mao L; Tang B; Vanderklish PW; Liao X; Xiong ZQ; Liao L
    Neurobiol Dis; 2019 Dec; 132():104585. PubMed ID: 31445164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
    Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
    Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards an understanding of Angelman syndrome in mice studies.
    Yang X
    J Neurosci Res; 2020 Jun; 98(6):1162-1173. PubMed ID: 31867793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome.
    Geerts-Haages A; Bossuyt SNV; den Besten I; Bruggenwirth H; van der Burgt I; Yntema HG; Punt AM; Brooks A; Elgersma Y; Distel B; Valstar M
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1481. PubMed ID: 32889787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons.
    Albrecht U; Sutcliffe JS; Cattanach BM; Beechey CV; Armstrong D; Eichele G; Beaudet AL
    Nat Genet; 1997 Sep; 17(1):75-8. PubMed ID: 9288101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE3A regulates the transcription of IRF, an antiviral immunity.
    Furumai R; Tamada K; Liu X; Takumi T
    Hum Mol Genet; 2019 Jun; 28(12):1947-1958. PubMed ID: 30690483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics Analyses of the Transcriptome Reveal Ube3a-Dependent Effects on Mitochondrial-Related Pathways.
    Panov J; Simchi L; Feuermann Y; Kaphzan H
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors.
    Heck DH; Zhao Y; Roy S; LeDoux MS; Reiter LT
    Hum Mol Genet; 2008 Jul; 17(14):2181-9. PubMed ID: 18413322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes.
    Mabb AM; Judson MC; Zylka MJ; Philpot BD
    Trends Neurosci; 2011 Jun; 34(6):293-303. PubMed ID: 21592595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial and temporal silencing of the human maternal UBE3A gene.
    Daily J; Smith AG; Weeber EJ
    Eur J Paediatr Neurol; 2012 Nov; 16(6):587-91. PubMed ID: 22560727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases.
    Chaudhary P; Proulx J; Park IW
    Virus Res; 2023 Oct; 335():199191. PubMed ID: 37541588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome.
    Colas D; Wagstaff J; Fort P; Salvert D; Sarda N
    Neurobiol Dis; 2005 Nov; 20(2):471-8. PubMed ID: 15921919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNURF-SNRPN and UBE3A transcript levels in patients with Angelman syndrome.
    Runte M; Kroisel PM; Gillessen-Kaesbach G; Varon R; Horn D; Cohen MY; Wagstaff J; Horsthemke B; Buiting K
    Hum Genet; 2004 May; 114(6):553-61. PubMed ID: 15014980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.